<p>GRIMES &amp; Co WEALTH MANAGEMENT LLC 在第三季度根據其最近向證券交易委員會提交的 13F 文件中獲得了 Cardinal Health, Inc. (NYSE:CAH - 免費報告) 的新頭寸。該基金購買了 5,192 股公司股票，價值約為 81.5 萬美元。</p>
<p>獲取 <strong>Cardinal Health</strong> 警報：</p>
<ul>
<li>對市場感到懷疑？3 只股票幫助你度過恐懼、不確定性和懷疑</li>
</ul>
<p>其他幾家機構投資者也增加或減少了在 CAH 的持股。SJS Investment Consulting Inc. 在第三季度將其在 Cardinal Health 的持股增加了 1,363.6%。SJS Investment Consulting Inc. 現在擁有 161 股公司股票，價值 25,000 美元，此前在上個季度購買了 150 股。Jones Financial Companies Lllp 在第一季度將其在 Cardinal Health 的持股增加了 198.3%。Jones Financial Companies Lllp 現在擁有 21,112 股公司股票，價值 27,000 美元，此前在上個季度購買了 14,034 股。Atlantic Edge Private Wealth Management LLC 在第二季度將其在 Cardinal Health 的持股增加了 75.0%。Atlantic Edge Private Wealth Management LLC 現在擁有 175 股公司股票，價值 29,000 美元，此前在上個季度購買了 75 股。Vermillion &amp; White Wealth Management Group LLC 在第二季度將其在 Cardinal Health 的持股增加了 55.0%。Vermillion &amp; White Wealth Management Group LLC 現在擁有 200 股公司股票，價值 34,000 美元，此前在此期間增加了 71 股。最後，Quent Capital LLC 在第三季度購買了 Cardinal Health 的新頭寸，價值約為 35,000 美元。目前 87.17% 的股票由對沖基金和其他機構投資者持有。</p>
<h2>分析師評級變動</h2>
<p>CAH 已成為多份研究分析師報告的主題。Wells Fargo &amp; Company 在 11 月 5 日的研究報告中將 Cardinal Health 的目標價從 185.00 美元上調至 221.00 美元，並給予該股票 “增持” 評級。瑞銀集團在 10 月 31 日的研究報告中將 Cardinal Health 的目標價從 185.00 美元上調至 220.00 美元，並給予該股票 “買入” 評級。Mizuho 在週一對 Cardinal Health 設定了 222.00 美元的目標價。Wall Street Zen 在 11 月 8 日的報告中將 Cardinal Health 的評級從 “買入” 上調至 “強力買入”。最後，Evercore ISI 在 10 月 31 日的研究報告中將 Cardinal Health 的目標價從 190.00 美元上調至 220.00 美元，並給予公司 “跑贏大盤” 評級。十四位投資分析師對該股票給予了買入評級，兩位分析師對該股票給予了持有評級。根據 MarketBeat，Cardinal Health 的共識評級為 “適度買入”，共識目標價為 214.07 美元。</p>
<ul>
<li>醫療技術股票受益於急性護理需求上升</li>
</ul>
<p><strong>獲取我們最新的 CAH 股票報告</strong></p>
<h2>Cardinal Health 股票上漲 2.7%</h2>
<p>NYSE CAH 週三開盤價為 208.08 美元。Cardinal Health, Inc. 的 52 周低點為 119.92 美元，52 周高點為 214.93 美元。該公司的市值為 494.4 億美元，市盈率為 31.38，市盈增長比率為 1.47，貝塔值為 0.65。該股票的 50 日移動平均價格為 204.54 美元，200 日移動平均價格為 173.77 美元。</p>
<ul>
<li>對於 Cardinal Health，證明將體現在其表現上</li>
</ul>
<p>Cardinal Health (NYSE:CAH - 獲取免費報告) 最近在 10 月 30 日發佈了其財報。公司報告每股收益（EPS）為 2.55 美元，超出市場共識預期的 2.22 美元，超出幅度為 0.33 美元。Cardinal Health 的淨利潤率為 0.68%，股本回報率為負 84.37%。公司在本季度的收入為 640.1 億美元，而分析師預期為 594.1 億美元。在去年同期，該公司每股收益為 1.88 美元。與去年同期相比，該公司的季度收入增長了 22.4%。Cardinal Health 已將其 2026 財年的指導目標設定為每股收益 9.650-9.850。研究分析師預計 Cardinal Health, Inc. 本年度將發佈每股收益 7.95 美元。</p>
<h2>Cardinal Health 股息公告</h2>
<p>公司最近還宣佈了一項季度股息，將於 1 月 15 日（星期四）支付。1 月 2 日（星期五）的登記投資者將獲得 0.5107 美元的股息。該股息的除息日期為 1 月 2 日（星期五）。這代表着每年 2.04 美元的股息，收益率為 1.0%。Cardinal Health 的股息支付比率目前為 30.77%。</p>
<h2>Cardinal Health 新聞摘要</h2>
<p>以下是本週影響 Cardinal Health 的主要新聞：</p>
<ul>
<li>積極情緒：Cardinal 將 2026 財年的每股收益指引上調至至少 10 美元，提到專業收入加速（目標超過 500 億美元）並宣佈了戰略勝利（IRA 轉型、新的 ContinuCare™ Pathway 和與 Publix 的合作）——這是管理層在摩根大通提到的核心催化劑。PR Newswire：Cardinal Health 上調 2026 財年展望</li>
<li>積極情緒：主要商業媒體指出，指引上調和專業增長敍述是股價上漲和投資者情緒改善的原因。Benzinga：Cardinal Health 提升 2026 年利潤展望</li>
<li>積極情緒：Barron’s 解釋了為什麼指引提升和專業收入軌跡使 2026 年成為股票的積極年份，增強了買方的興趣。Barron's：Cardinal Health 股票因指引上調而上漲</li>
<li>中性情緒：公司完整的摩根大通演示/文字記錄提供了戰略執行的細節，並用於支持指引更新；對建模有用，但在頭條指引上沒有新內容。Seeking Alpha：摩根大通演示文字記錄</li>
<li>中性情緒：分析師的覆蓋和公允價值觀點正在上升，因為賣方模型納入了更強的 2026 財年指引和專業勢頭。Yahoo Finance：分析師升級與專業聚焦</li>
<li>消極情緒：12 月空頭頭寸顯著上升（約 23.6% 的增長至約 606 萬股），如果情緒逆轉，可能增加下行風險或波動性。（未提供文章鏈接）</li>
<li>消極情緒：一些評論質疑在經歷多年上漲和股價大幅上漲後的估值——投資者應權衡業績/指引與溢價倍數。Yahoo Finance：Cardinal Health 是否已經漲得太遠？</li>
</ul>
<h2>Cardinal Health 公司簡介</h2>
<p>（免費報告）</p>
<p>Cardinal Health 是一家總部位於俄亥俄州都柏林的跨國醫療服務和產品公司。追溯到 1970 年代初，該公司已成長為醫療行業供應鏈和分銷服務的主要提供商。Cardinal Health 在多個服務領域運營，支持醫院、健康系統、藥房、醫生辦公室和臨牀實驗室。</p>
<p>公司的核心業務包括品牌和仿製藥的批發分銷、醫療外科產品的供應和分銷，以及物流和庫存管理解決方案的提供。</p>
<h2>進一步閲讀</h2>
<ul>
<li>我們更看好的五隻股票，勝過 Cardinal Health</li>
<li>這隻 15 美元的股票可能會成為 2026 年的第一隻股票</li>
<li>股票即將迎來 “凶兆日”……</li>
<li>將這些代碼輸入到您的普通經紀賬户中</li>
<li>崩盤已經開始（大多數人只是看不見）</li>
<li>崩盤前一個月</li>
</ul>
<p><strong>想看看其他對 CAH 感興趣的對沖基金持有哪些股票嗎？</strong> 訪問 HoldingsChannel.com 獲取 Cardinal Health, Inc. (NYSE:CAH - 免費報告) 的最新 13F 文件和內部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNBSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNBSA"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1000 美元在 Cardinal Health 嗎？</h2>
<p>在考慮 Cardinal Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄推薦給客户的股票，建議在更廣泛的市場注意到之前購買……而 Cardinal Health 並不在名單上。</p>
<p>雖然 Cardinal Health 目前在分析師中獲得中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

卡地納健康

<p>GRIMES & Co WEALTH MANAGEMENT LLC 已在 Cardinal Health, Inc. (NYSE:CAH) 中獲得了一個新頭寸，購買了 5,192 股，價值約 815,000 美元。這一收購是多個機構投資者增加在 Cardinal Health 持股的趨勢的一部分。分析師們提高了對該股票的目標價，普遍評級為 “適度買入”，目標價為 214.07 美元。Cardinal Health 最近報告了強勁的收益，超出預期，並宣佈季度股息為 0.5107 美元，反映出 1.0% 的收益率</p>

<p>GRIMES &amp; Co WEALTH MANAGEMENT LLC acquired a new position in Cardinal Health, Inc. (NYSE:CAH - Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 5,192 shares of the company's stock, valued at approximately $815,000.</p>
<div class="lb-trans"><p>GRIMES &amp; Co WEALTH MANAGEMENT LLC 在第三季度根據其最近向證券交易委員會提交的 13F 文件中獲得了 Cardinal Health, Inc. (NYSE:CAH - 免費報告) 的新頭寸。該基金購買了 5,192 股公司股票，價值約為 81.5 萬美元。</p>
</div><p>Get <strong>Cardinal Health</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Cardinal Health</strong> 警報：</p>
</div><ul>
<li>Doubt the Market? 3 Stocks to Rideout Fear, Uncertainty and Doubt</li>
</ul>
<div class="lb-trans"><ul>
<li>對市場感到懷疑？3 只股票幫助你度過恐懼、不確定性和懷疑</li>
</ul>
</div><p>Several other institutional investors have also added to or reduced their stakes in CAH. SJS Investment Consulting Inc. raised its stake in shares of Cardinal Health by 1,363.6% in the third quarter. SJS Investment Consulting Inc. now owns 161 shares of the company's stock worth $25,000 after purchasing an additional 150 shares during the last quarter. Jones Financial Companies Lllp increased its holdings in Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock worth $27,000 after buying an additional 14,034 shares in the last quarter. Atlantic Edge Private Wealth Management LLC raised its position in Cardinal Health by 75.0% in the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company's stock worth $29,000 after buying an additional 75 shares during the last quarter. Vermillion &amp; White Wealth Management Group LLC lifted its stake in Cardinal Health by 55.0% during the 2nd quarter. Vermillion &amp; White Wealth Management Group LLC now owns 200 shares of the company's stock valued at $34,000 after acquiring an additional 71 shares during the period. Finally, Quent Capital LLC bought a new position in Cardinal Health during the 3rd quarter valued at about $35,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>其他幾家機構投資者也增加或減少了在 CAH 的持股。SJS Investment Consulting Inc. 在第三季度將其在 Cardinal Health 的持股增加了 1,363.6%。SJS Investment Consulting Inc. 現在擁有 161 股公司股票，價值 25,000 美元，此前在上個季度購買了 150 股。Jones Financial Companies Lllp 在第一季度將其在 Cardinal Health 的持股增加了 198.3%。Jones Financial Companies Lllp 現在擁有 21,112 股公司股票，價值 27,000 美元，此前在上個季度購買了 14,034 股。Atlantic Edge Private Wealth Management LLC 在第二季度將其在 Cardinal Health 的持股增加了 75.0%。Atlantic Edge Private Wealth Management LLC 現在擁有 175 股公司股票，價值 29,000 美元，此前在上個季度購買了 75 股。Vermillion &amp; White Wealth Management Group LLC 在第二季度將其在 Cardinal Health 的持股增加了 55.0%。Vermillion &amp; White Wealth Management Group LLC 現在擁有 200 股公司股票，價值 34,000 美元，此前在此期間增加了 71 股。最後，Quent Capital LLC 在第三季度購買了 Cardinal Health 的新頭寸，價值約為 35,000 美元。目前 87.17% 的股票由對沖基金和其他機構投資者持有。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析師評級變動</h2>
</div><p>CAH has been the subject of a number of research analyst reports. Wells Fargo &amp; Company lifted their price target on shares of Cardinal Health from $185.00 to $221.00 and gave the stock an &#34;overweight&#34; rating in a research note on Wednesday, November 5th. UBS Group lifted their target price on shares of Cardinal Health from $185.00 to $220.00 and gave the stock a &#34;buy&#34; rating in a research report on Friday, October 31st. Mizuho set a $222.00 price target on Cardinal Health in a report on Monday. Wall Street Zen raised Cardinal Health from a &#34;buy&#34; rating to a &#34;strong-buy&#34; rating in a report on Saturday, November 8th. Finally, Evercore ISI upped their price objective on Cardinal Health from $190.00 to $220.00 and gave the company an &#34;outperform&#34; rating in a research report on Friday, October 31st. Fourteen investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, Cardinal Health has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $214.07.</p>
<div class="lb-trans"><p>CAH 已成為多份研究分析師報告的主題。Wells Fargo &amp; Company 在 11 月 5 日的研究報告中將 Cardinal Health 的目標價從 185.00 美元上調至 221.00 美元，並給予該股票 “增持” 評級。瑞銀集團在 10 月 31 日的研究報告中將 Cardinal Health 的目標價從 185.00 美元上調至 220.00 美元，並給予該股票 “買入” 評級。Mizuho 在週一對 Cardinal Health 設定了 222.00 美元的目標價。Wall Street Zen 在 11 月 8 日的報告中將 Cardinal Health 的評級從 “買入” 上調至 “強力買入”。最後，Evercore ISI 在 10 月 31 日的研究報告中將 Cardinal Health 的目標價從 190.00 美元上調至 220.00 美元，並給予公司 “跑贏大盤” 評級。十四位投資分析師對該股票給予了買入評級，兩位分析師對該股票給予了持有評級。根據 MarketBeat，Cardinal Health 的共識評級為 “適度買入”，共識目標價為 214.07 美元。</p>
</div><ul>
<li>Medical Technology Stock Benefits from Rising Acute Care Demand</li>
</ul>
<div class="lb-trans"><ul>
<li>醫療技術股票受益於急性護理需求上升</li>
</ul>
</div><p><strong>Get Our Latest Stock Report on CAH</strong></p>
<div class="lb-trans"><p><strong>獲取我們最新的 CAH 股票報告</strong></p>
</div><h2>Cardinal Health Stock Up 2.7%</h2>
<div class="lb-trans"><h2>Cardinal Health 股票上漲 2.7%</h2>
</div><p>NYSE CAH opened at $208.08 on Wednesday. Cardinal Health, Inc. has a 52 week low of $119.92 and a 52 week high of $214.93. The company has a market capitalization of $49.44 billion, a P/E ratio of 31.38, a price-to-earnings-growth ratio of 1.47 and a beta of 0.65. The stock's 50-day moving average price is $204.54 and its 200-day moving average price is $173.77.</p>
<div class="lb-trans"><p>NYSE CAH 週三開盤價為 208.08 美元。Cardinal Health, Inc. 的 52 周低點為 119.92 美元，52 周高點為 214.93 美元。該公司的市值為 494.4 億美元，市盈率為 31.38，市盈增長比率為 1.47，貝塔值為 0.65。該股票的 50 日移動平均價格為 204.54 美元，200 日移動平均價格為 173.77 美元。</p>
</div><ul>
<li>For Cardinal Health, the Proof Will be in Its Performance</li>
</ul>
<div class="lb-trans"><ul>
<li>對於 Cardinal Health，證明將體現在其表現上</li>
</ul>
</div><p>Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.22 by $0.33. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The company had revenue of $64.01 billion during the quarter, compared to analyst estimates of $59.41 billion. During the same period in the prior year, the firm posted $1.88 EPS. The firm's quarterly revenue was up 22.4% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Research analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current year.</p>
<div class="lb-trans"><p>Cardinal Health (NYSE:CAH - 獲取免費報告) 最近在 10 月 30 日發佈了其財報。公司報告每股收益（EPS）為 2.55 美元，超出市場共識預期的 2.22 美元，超出幅度為 0.33 美元。Cardinal Health 的淨利潤率為 0.68%，股本回報率為負 84.37%。公司在本季度的收入為 640.1 億美元，而分析師預期為 594.1 億美元。在去年同期，該公司每股收益為 1.88 美元。與去年同期相比，該公司的季度收入增長了 22.4%。Cardinal Health 已將其 2026 財年的指導目標設定為每股收益 9.650-9.850。研究分析師預計 Cardinal Health, Inc. 本年度將發佈每股收益 7.95 美元。</p>
</div><h2>Cardinal Health Dividend Announcement</h2>
<div class="lb-trans"><h2>Cardinal Health 股息公告</h2>
</div><p>The company also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be issued a $0.5107 dividend. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $2.04 annualized dividend and a yield of 1.0%. Cardinal Health's dividend payout ratio is currently 30.77%.</p>
<div class="lb-trans"><p>公司最近還宣佈了一項季度股息，將於 1 月 15 日（星期四）支付。1 月 2 日（星期五）的登記投資者將獲得 0.5107 美元的股息。該股息的除息日期為 1 月 2 日（星期五）。這代表着每年 2.04 美元的股息，收益率為 1.0%。Cardinal Health 的股息支付比率目前為 30.77%。</p>
</div><h2>Cardinal Health News Summary</h2>
<div class="lb-trans"><h2>Cardinal Health 新聞摘要</h2>
</div><p>Here are the key news stories impacting Cardinal Health this week:</p>
<div class="lb-trans"><p>以下是本週影響 Cardinal Health 的主要新聞：</p>
</div><ul>
<li>Positive Sentiment: Cardinal raised FY‑2026 EPS guidance to at least $10, cited accelerating specialty revenue (&gt;$50B target) and announced strategic wins (IRA transition, new ContinuCare™ Pathway and a Publix partnership) — the core catalyst cited by management at J.P. Morgan. PR Newswire: Cardinal Health Raises Fiscal 2026 Outlook</li>
<li>Positive Sentiment: Major business-media pieces note the guidance raise and specialty growth narrative as the reason for the stock jump and upgraded investor sentiment. Benzinga: Cardinal Health Lifts 2026 Profit Outlook</li>
<li>Positive Sentiment: Barron’s explained why the guidance lift and specialty revenue trajectory make 2026 a constructive year for the stock, reinforcing buy‑side interest. Barron's: Cardinal Health Stock Jumps on Guidance Raise</li>
<li>Neutral Sentiment: The company’s full J.P. Morgan presentation/transcript provides detail on strategy execution and was used to support the guidance update; useful for modeling but not new on the headline guidance. Seeking Alpha: J.P. Morgan Presentation Transcript</li>
<li>Neutral Sentiment: Analyst coverage and fair‑value views are shifting upward as sell‑side models incorporate the stronger FY26 guide and specialty momentum. Yahoo Finance: Analyst Upgrades &amp; Specialty Focus</li>
<li>Negative Sentiment: Short interest rose materially in December (≈23.6% increase to ~6.06M shares), which can add downside risk or volatility if sentiment reverses. (No article link provided)</li>
<li>Negative Sentiment: Some commentary questions valuation after a multi‑year run and steep share gains — investors should weigh the beat/guidance versus premium multiples. Yahoo Finance: Has Cardinal Health Run Too Far?</li>
</ul>
<div class="lb-trans"><ul>
<li>積極情緒：Cardinal 將 2026 財年的每股收益指引上調至至少 10 美元，提到專業收入加速（目標超過 500 億美元）並宣佈了戰略勝利（IRA 轉型、新的 ContinuCare™ Pathway 和與 Publix 的合作）——這是管理層在摩根大通提到的核心催化劑。PR Newswire：Cardinal Health 上調 2026 財年展望</li>
<li>積極情緒：主要商業媒體指出，指引上調和專業增長敍述是股價上漲和投資者情緒改善的原因。Benzinga：Cardinal Health 提升 2026 年利潤展望</li>
<li>積極情緒：Barron’s 解釋了為什麼指引提升和專業收入軌跡使 2026 年成為股票的積極年份，增強了買方的興趣。Barron's：Cardinal Health 股票因指引上調而上漲</li>
<li>中性情緒：公司完整的摩根大通演示/文字記錄提供了戰略執行的細節，並用於支持指引更新；對建模有用，但在頭條指引上沒有新內容。Seeking Alpha：摩根大通演示文字記錄</li>
<li>中性情緒：分析師的覆蓋和公允價值觀點正在上升，因為賣方模型納入了更強的 2026 財年指引和專業勢頭。Yahoo Finance：分析師升級與專業聚焦</li>
<li>消極情緒：12 月空頭頭寸顯著上升（約 23.6% 的增長至約 606 萬股），如果情緒逆轉，可能增加下行風險或波動性。（未提供文章鏈接）</li>
<li>消極情緒：一些評論質疑在經歷多年上漲和股價大幅上漲後的估值——投資者應權衡業績/指引與溢價倍數。Yahoo Finance：Cardinal Health 是否已經漲得太遠？</li>
</ul>
</div><h2>Cardinal Health Company Profile</h2>
<div class="lb-trans"><h2>Cardinal Health 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.</p>
<div class="lb-trans"><p>Cardinal Health 是一家總部位於俄亥俄州都柏林的跨國醫療服務和產品公司。追溯到 1970 年代初，該公司已成長為醫療行業供應鏈和分銷服務的主要提供商。Cardinal Health 在多個服務領域運營，支持醫院、健康系統、藥房、醫生辦公室和臨牀實驗室。</p>
</div><p>The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.</p>
<div class="lb-trans"><p>公司的核心業務包括品牌和仿製藥的批發分銷、醫療外科產品的供應和分銷，以及物流和庫存管理解決方案的提供。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Cardinal Health</li>
<li>This $15 Stock Could Go Down as the #1 Stock of 2026</li>
<li>“Ominous day” coming to stocks…</li>
<li>Punch these codes into your ordinary brokerage account</li>
<li>The Crash Has Already Started (Most Just Don’t See It Yet)</li>
<li>A month before the crash</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，勝過 Cardinal Health</li>
<li>這隻 15 美元的股票可能會成為 2026 年的第一隻股票</li>
<li>股票即將迎來 “凶兆日”……</li>
<li>將這些代碼輸入到您的普通經紀賬户中</li>
<li>崩盤已經開始（大多數人只是看不見）</li>
<li>崩盤前一個月</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding CAH?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對 CAH 感興趣的對沖基金持有哪些股票嗎？</strong> 訪問 HoldingsChannel.com 獲取 Cardinal Health, Inc. (NYSE:CAH - 免費報告) 的最新 13F 文件和內部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNBSA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=CAH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Cardinal Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 Cardinal Health 嗎？</h2>
</div><p>Before you consider Cardinal Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Cardinal Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄推薦給客户的股票，建議在更廣泛的市場注意到之前購買……而 Cardinal Health 並不在名單上。</p>
</div><p>While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Cardinal Health 目前在分析師中獲得中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

GRIMES & Co WEALTH MANAGEMENT LLC 購入了卡地納健康公司（Cardinal Health, Inc.）的新頭寸 $CAH